Clinical Trial Update: Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating four escalating dose regimens of TPI ASM8 in patients with allergic asthma, reporting efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TPI ASM8

Snippet

Sponsor: Syntara | Conditions: Asthma | Phase 2 | Status: COMPLETED